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Abstract
Tuberous Sclerosis Complex (TSC) is a genetic hamartoma syndrome frequently associ-
ated with severe intractable epilepsy. In some TSC patients epilepsy surgery is a promising
treatment option provided that the epileptogenic zone can be precisely delineated. TSC
brain lesions (cortical tubers) contain dysmorphic neurons, brightly eosinophilic giant cells
and white matter alterations in various proportions. However, a histological classification
system has not been established for tubers. Therefore, the aim of this study was to define
distinct histological patterns within tubers based on semi-automated histological quantifica-
tion and to find clinically significant correlations. In total, we studied 28 cortical tubers and
seven samples of perituberal cortex from 28 TSC patients who had undergone epilepsy sur-
gery. We assessed mammalian target of rapamycin complex 1 (mTORC1) activation, the
numbers of giant cells, dysmorphic neurons, neurons, and oligodendrocytes, and calcifica-
tion, gliosis, angiogenesis, inflammation, and myelin content. Three distinct histological pro-
files emerged based on the proportion of calcifications, dysmorphic neurons and giant cells
designated types A, B, and C. In the latter two types we were able to subsequently associ-
ate them with specific features on presurgical MRI. Therefore, these histopathological pat-
terns provide consistent criteria for improved definition of the clinico-pathological features of
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Introduction
Tuberous Sclerosis Complex (TSC) is a genetic disease affecting about 1:6,000 live births [1].
TSC is characterized by an age-dependent manifestation of primarily non-malignant tumors in
many different organ systems [2]. In TSC, almost 90% of the affected individuals will suffer
from recurrent seizures [3], and thus most patients are diagnosed after the onset of seizures in
infancy or early childhood [2]. Only about a third of patients can be treated successfully with
anti-epileptic drugs. In the remaining individuals, resective surgery of the corresponding epi-
leptogenic zone (EZ) may be considered [4]. Defining the EZ is a major challenge in TSC
patients since the EZ might not be restricted to one single tuber. Therefore, selected patients
often undergo intracranial electroencephalography (EEG) evaluation to localize accurately the
EZ and eloquent cortex prior to the determination of the resection area. This procedure is an
additional risk factor and burden to patients [5]. After epilepsy surgery, 57% of patients achieve
seizure freedom and another 18% show a significant reduction in seizure frequency at a mini-
mum of one year follow-up [6]. In addition to seizure freedom, psychomotor development
may also improve [6]. However, approximately 25% of patients have unfavorable outcomes
after surgery, with ongoing seizures and, in about 3% of cases, major surgical morbidity [7].
Therefore, it is urgent to identify those TSC patients who will significantly benefit from epi-
lepsy surgery, and hence, there is a great need for a clear-cut definition of the EZ, based on
imaging-, neurophysiological-, and source localization techniques.
TSC is caused by a mutation of either of two genes, TSC1 and TSC2, which encode the pro-
teins TSC1 (hamartin) and TSC2 (tuberin), respectively [3]. These proteins are involved in
numerous regulatory processes via the regulation of the mTOR signaling pathway including
cell growth, proliferation, migration and differentiation. In the first reported case series about
90% had cerebral manifestations, including cortical tubers [8]. Histologically, cortical tubers
present with a distorted cortical architecture, and contain dysmorphic neurons with aberrant
Nissl substance and bright eosinophilic giant cells. It has been proposed that these aberrant
cells play an essential role in epileptogenesis [9]. However, recent data from intracranial
recordings indicate that the perilesional cortex also plays an important role [10].
We examined cortical tubers and perituberal cortex samples using multiple biomarkers
from TSC patients who previously underwent epilepsy surgery as a strategy to classify the his-
tological severity of tubers and potentially aid with future evaluation of the EZ in TSC patients.
Using quantitative histology and a dedicated imaging program, we assessed a number of
cellular features, including mTORC1 activation, amount of neurons, dysmorphic neurons, cal-
cification, gliosis, giant cells, vessels, inflammatory markers, myelin content and amount of oli-
godendroglial cells. The results were cross-referenced to clinical data, and analyzed statistically.
Material & Methods
Subjects
We critically evaluated 28 tubers from whom we received anatomically well preserved, en bloc
resected neocortical tissue and sufficient clinical data (Department of Pediatric Neurology,
Brain Center Rudolf Magnus, University Medical Center Utrecht; Department of Pediatric
Neurology, Charles University, 2nd Medical School, Motol University Hospital, Prague and
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Department of Pediatrics, Medical University Vienna; median age at resection = 6.00 years;
range = 0.83–47 years; localization: 17 frontal, 8 temporal and 3 parietal; gender: 17 males, 11
females). Extensive presurgical evaluation including 24hours to 5 days video-EEG monitoring,
high-resolution MRI and neuropsychological testing was performed in each patient in order to
characterize the EZ, and to select candidates for tailored surgical resection. We included also 7
perituberal samples which were defined by absence of dysmorphic neurons and giant cells on
histology (whole tissue blocs to ensure equality in available grey and white matter).
The age- and localization-matched control group consisted of 23 autopsy cases (median
age = 2.00 years; range = 0.1–17 years; localization: 7 frontal, 9 temporal, 7 occipital; gender: 10
males, 13 females; post mortem delay = 24h). None of these patients had a history of seizures
or other neurological diseases. All control samples have been collected at the Department of
(Neuro)Pathology, AMC, Amsterdam, The Netherlands.
Tissue was obtained and used in accordance with the Declaration of Helsinki and the AMC
Research Code provided by the Medical Ethics Committee and approved by the science com-
mittee of the UMC Utrecht Biobank. This study was also approved by the Ethical Committee
of the Medical University of Vienna and the Ethical Committee of the Motol University Hos-
pital in Prague. Written informed consent was obtained from all patients included into our
study.
Tissue preparation and staining protocols
The tissue was carefully oriented, cut perpendicular to the pial surface, fixed overnight in 4%
formaldehyde and routinely processed into liquid paraffin. Sections were cut at 4–6 μmwith a
microtome (Microm, Heidelberg, Germany), and mounted on positively charged slides (Super-
frost + Menzel, Germany). Each specimen was histopathologically examined using haematoxy-
lin & eosin (H & E). An immunohistochemical examination of all surgical specimens was
performed using the following panel of antibodies: Olig2 (oligodendrocyte lineage transcrip-
tion factor 2, 1:100 dilution, IBL, Minneapolis, USA), NeuN (neuronal nuclei, 1:100, clone
A60, Chemicon, Billerica, MA, USA), non-phosphorylated neurofilament H (1:1000, clone
SMI32, Sternberger, Lutherville), GFAP (glial fibrillary acidic protein, 1:4000, Dako, Glostrup,
Denmark), CD3 (cluster of differentiation 3, 1:200, clone F7.2.38, DAKO), HLA-DP, DR, DQ
(human leukocyte antigen class II, 1:100, clone Cr3/43, DAKO), pS6 (phosphorylated S6-ribo-
somal protein, 1:1200, Ser235/236, Cell Signalling Technology, Danvers, MA, USA), MBP
(myelin binding protein, 1:400, DAKO), CD34 (cluster of differentiation 34, 1:600, Qbend,
Immunotech) and vimentin (1:500, clone V9, Dako). Autopsy cases were pre-treated with 1%
Triton X-100 (for 1 h) prior to incubation with anti-Olig2 antibody. The slides were air dried
overnight at 37°C. All immunohistochemical stainings were performed with a Ventana semiau-
tomated staining machine (Benchmark ULTRA; Ventana, Illkirch, France) and the Ventana
DAB staining system according to the manufacturer’s protocol.
Semi-quantitative measurements
Slides were scanned with an Olympus dotSlide system (vs 2.5, Olympus, Tokyo, Japan). Digi-
tal slide scans were obtained at a 100x magnification with a resolution of 0.64μm/pixel. Scans
were exported as a homogeneous set of.TIFF files, each with an equal image size of 50MB.
Files without visible tissue were discarded. Qualitative and semi-quantitative image analysis
was performed with the Image-Pro Premiere software package v. 9.1 (Media Cybernatics,
USA). The mean and standard deviation was calculated for every parameter and used for sta-
tistical analysis.
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Calcifications
The presence or absence of calcifications was scored based on the H&E staining This was con-
verted into a nominal variable of 0 and 1.
Giant cells
The numbers of giant cells per mm2 were calculated from 10 representative fields (each repre-
senting 1.081mm2) of an anti-vimentin stained section.
Microglial activation, gliosis, mTORC1 activation and myelin content
Quantification of all available tissue was taken into account. In a first step the total tissue sur-
face area was calculated for each case utilizing the smart segmentation tool provided by the
ImagePro software package. Second, the DAB positive area (anti-Cr3/43, anti-GFAP, anti-
pS6-Ser235/236 and anti-MBP) was separated from background using an adjusted protocol for
segmentation (S1 Fig). All stacks of images were submitted to a batch processing algorithm
that was kept consistent throughout the whole analysis. In a final step, the overall percentage of
positivity was assessed for each case and used for statistical analysis. In the myelin stainings we
further addressed the optical density (OD) of the MBP positive area. The integrated OD of
MBP was also used. For simplicity and due to the linear correlation (p< 0.001), the product of
intensity x frequency (percentage x OD) was calculated. This product is further referred to as
overall myelin content (OMC).
Cellular densities
For the calculation of cellular densities the available images were split into RGB channels. To
establish the positive count a brightness threshold in the blue channel was determined for each
staining (NeuN: 120; CD3, SMI32 and Olig2: 100; CD34: 150) and size ranges were defined to
allow more accurate counts (pixel areas: NeuN: 120–2500; CD3: 20–155; Olig2: 20–155 in sur-
gical tissue and 5–120 in autopsy material; CD34: 100-unlimited; SMI32: 750–5000). These
parameters were kept the same throughout the analysis and were also implemented in the
batch processing algorithm. All cellular densities are represented as total number/mm2.
Clinical data
All available MRIs were retrospectively reviewed and the resected tubers were scored according
to the classification system proposed by Gallagher et al. [11]. The presence of “focal cortical
dysplasia (FCD)-like” features (thickened cortex and blurred grey-white matter border in areas
surrounding one or several tubers and presence of transmantle sign) were assessed as well as
the presence of calcifications. In addition, the following clinical data was obtained: TSC1/TSC2
mutation status, gender, age at seizure onset, localization of the resected area, age at epilepsy
onset, mean seizure frequency (daily-weekly-monthly), antiepileptic drug (AED) management
at surgery, type of epilepsy surgery, duration of active epilepsy, last available postsurgical sei-
zure outcome (according to Engel’s score), average intelligence quotient (IQ) with global cogni-
tive performance and presence/absence of autism [12].
Interobserver agreement
For case evaluation, six different neuropathologists gained access to an online virtual slide sys-
tem (Digital Slidebox 4.5, Slidepath; Leica Microsystems, Dublin, Ireland). These reviewers
were asked to classify a subset of ten randomly selected cases provided with three basic stain-
ings (H&E, SMI32 and vimentin) according to the novel scheme of patterns discussed in this
Histological Patterns in TSC Cortical Tubers
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manuscript. After 21 days the platform was closed. None of the reviewers had access to the
results of the others.
Statistical analysis
Statistical analysis was performed on SPSS 21 (IBM, PASW Statistics, USA). The distributions
of pS6, SMI32 and vimentin were left skewed. Therefore, the data were log-transformed prior
to statistical analysis. Hierarchical clustering (Ward’s method with squared Euclidian dis-
tances) and one-way ANOVA were used for specify the tuber patterns (S2 Fig). Due to the lack
of normality and non-equality of variances non-parametric testing (independent-sample Krus-
kal-Wallis test) as well as Kendall-tau correlation were used to analyse the data. Partial correla-
tion was applied if data needed to be corrected for another variable. The Chi-squared test was
applied for analysing categorical data. The κ coefficient was calculated to address inter-rater
variability. In our study κ was interpreted as follows:<0.2, poor agreement; 0.2–<0.4, fair
agreement; 0.4–<0.6, moderate agreement; 0.6–<0.8, good agreement; 0.8–1.0, very good
agreement. Bootstrapping was conducted on 1000 samples with bias-corrected and accelerated
confidence intervals. P-values were considered significant if< 0.05.
Results
Patterns of cortical tubers
In order to find differences in histological appearance the three most accessible features of a
cortical tuber (mTORC1 activation, dysmorphic neurons and giant cells) were admitted to a
hierarchical cluster analysis. As a result, the tubers were divided into three different clusters
(S2 Fig). To determine the main histological discriminants between the clusters a one-way
ANOVA was performed. There were significant differences in the numbers of dysmorphic
neurons (p = 0.000) and giant cells (p = 0.001) whereas pS6-Ser235/236 positivity failed to
reach significance. Tubers were then independently analyzed by two neuropathologists experi-
enced in evaluating epilepsy surgery specimens (Angelika Mühlebner and Eleonora Aronica)
and the microscopic assessment of the clusters revealed three different patterns. These were
translated into the following qualitative criteria:
1. low density of giant cells 10/mm2 or dysmorphic neurons 3/mm2 (Fig 1B)
Fig 1. Histology of tuber variants. A. Perilesional cortex (Cx) and white matter (WM) of an 8-year old male
patient.B. Type A tuber (Cx andWM) in a 5-year old female patient with a tuber in the frontal lobe. C. Type B
tuber (Cx andWM) located in the parietal lobe of an 8-year old boy (same as in Fig 1A). D. Type C tuber of a
2-year old male patient located in the frontal lobe. Scale bar in D = 100μm and applies also to A, B and C.
doi:10.1371/journal.pone.0157396.g001
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2. high density of giant cells> 10/mm2 or dysmorphic neurons> 3/mm2 (Fig 1C)
3. giant cells, dysmorphic neurons and calcifications (Fig 1D)
We submitted a randomly selected subset of cases to an online platform in order to validate
our findings among other trained neuropathologists (six participants). The inter-observer
agreement was very good (κ = 0.973).
The following quantitative analysis was based on 28 available tuber specimens. Subse-
quently, our cohort consisted of 7 type A tubers (median age = 10.00 years, range 3–47 years; 6
males, 1 females; 5 frontal, 2 temporal), 13 type B tubers (median age = 7 years, range 0.83–22
years; 6 males, 7 females; 4 frontal, 6 temporal, 2 parietal, 1 hemispheric) and 8 type C tubers
(median age = 3 years, range 1–6 years; 5 males, 3 females; 7 frontal, 1 parietal).
mTORC1 activation, neuronal quantity and gliosis
In our cohort we compared with histologically normal cortex to clarify the role of perituberal
cortex. Independent-sample Kruskal-Wallis testing revealed no differences in mTORC1 activa-
tion among the tuber types and perilesional samples (Fig 2A–2E). However, mTORC1 activa-
tion was significantly increased in all samples compared to controls (H[4] = 22.942, p = 0.000).
Interestingly, in the distribution of NeuN positive cells/mm2 varied significantly among the
subgroups (H[3] = 10.416, p = 0.015; median and range of all quantification data see Table 1).
However, subsequent pairwise comparison did not reveal significant changes. We could how-
ever observe a tendency in type B tubers to show decreased neuronal cell counts (Fig 2F–2J).
Fig 2. mTORC1 activation, neuronal quantity and gliosis. A.—D.mTOR activation was present in all cortical tuber types as well as in
perituberal cortex (pS6-Ser235/236 staining). E.Gradient mTOR activation among the tuber types. F.—I. Loss in neuronal cell density could be
observed in type B tubers (NeuN staining). J. Neurons were significantly depleted (p = 0.015). K.—N.Gliosis was present in all tuber types
(GFAP staining).O. Increase of gliosis reached significance (p = 0.019). Scale bar in D, I, and N = 100μm and applies also to F,G, H, K, L, and
M. CO = control; PT = perituberal cortex.
doi:10.1371/journal.pone.0157396.g002
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Quantification of GFAP positivity revealed a variation in distribution among the groups (H[3]
= 9.943, p = 0.019; Table 1). Pairwise comparison showed a significant increase of GFAP den-
sity in type B tubers when compared to perituberal samples (p = 0.023). All calculations were
based upon 28 tuber samples and 7 perituberal cortex specimens. Subgroup analysis revealed
no correlation of mTORC1 activation, neuronal density or gliosis with the localization of the
tuber. However, the amount of GFAP positivity was negatively correlated with the age at sur-
gery (Kendall-tau, R = -0.271, p = 0.025).
To broaden our knowledge of these novel patterns we subsequently introduced an age- and
region-matched control group to see whether the subgroups differ from autopsy controls.
Inflammation and small vessel density
An increase in inflammatory cells in cortical tubers has been previously shown [13]. The
amount of T-cells (CD3 positive cells/mm2) was significantly affected by the tuber type (H[4]
= 16.730, p = 0.002; Table 1). We confirmed a gain of inflammatory markers in type B and C
tubers compared to postmortem control in a pairwise comparison (B: p = 0.047; C: p = 0.012;
Fig 3A, 3B and 3C). A similar pattern was be observed in microglial activation (percentage of
Cr3/43 positivity; H[4] = 16.417, p = 0.003; Table 1; Fig 3E–3G). Type B and C tubers showed a
significant gain in microglial activation (B: p = 0.016; C: p = 0.005) compared to control (Fig
3H). No differences could be detected for type A tubers. Furthermore, we were able to detect
a difference in small vessel density (CD34 staining) among the categories (H[4] = 12.835,
p = 0.012; Table 1). However, pairwise comparison failed to reach significance when directly
compared to autopsy brain specimens.
Myelin content and oligodendroglial cell count
Within the tuber patterns we were able to observe myelin loss whereas there was no difference
in oligodendroglial cell count (Fig 4A, 4B, 4D and 4E). The overall myelin content (OMC,
based on MBP) was altered among the different categories (H[4] = 11.691, p = 0.020; Table 1;
Fig 4C).
Table 1. Quantification.
Classiﬁcation
Median
(range)
type A type B type C Perituberal control p-
value
pS6 (%) 1.73 (0.84–4.09) 1.53(0.63–6.64) 4.14(0.88–6.82) 0.70(0.44–3.64) 0.18 (0.03–0.67) 0.000
neurons/mm2 261.20(106.56–296.26) 139.18(32.03–
258.29)
175.88(55.70–
277.31)
256.63(126.69–459.07) 351.39(275.69–540.46) 0.015
GFAP (%) 16.87(1.01–44.41) 18.34(8.16–34.06) 13.87(7.09–34.02) 5.89(2.15–12.78) 5.61(2.25–9.34) 0.019
T-cells/mm2 7.70(4.23–19.32) 13.81(7.38–35.85) 22.64(7.29–34.20) 9.08(1.91–13.55) 5.54(0.56–29.76) 0.002
Cr3/43 (%) 3.10(0.21–7.63) 2.16(0.25–33.24) 5.14(0.26–11.66) .95(0.11–2.50) .51(0.07–1.70) 0.003
vessels/mm2 73.85(36.65–169.35) 73.90(40.06–190.45) 114.48(77.57–
154.12)
66.93(28.49–114.06) 130.41(36.77–239.79) 0.012
OMC (%lum) 389.95(161.97–
3185.74)
196.23(0.24–
8110.52)
273.460.01–
3168.69)
2711.58(909.27–
6869.83)
2801.68(188.05–
5815.44)
0.020
oligos/mm2 159.22(9.51–405.16) 103.03(20.51–
390.42)
133.31(66.73–
832.46)
184.98(109.86–334.99) 208.17(88.01–522.37) >0.05
All available quantiﬁcation data of the image analysis study. Signiﬁcance levels are presented in the last column.
doi:10.1371/journal.pone.0157396.t001
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Neither OMC nor the number of olig2 positive cells were related to age or localization in
controls. There was no significant difference between autopsy and perituberal samples.
Correlations with clinical data
There was no relation between the tuber types according to Gallagher et al. [11] detected on
MRI and the histological tuber classification on the sequences available (Fig 5A–5C). However,
FCD-like features assessed on presurgical MRI were significantly related with histological type
B and C tubers (X2; p = 0.037). Interestingly, a lower drug load (measured by the number of
antiepileptic drugs [AED] taken at the time of the surgery) was associated with type A tubers
Fig 3. Inflammatory markers and vessel structure. A. Representative amount of T-cells lying in the white matter (WM) of control samples
(CD3 staining). B. + C. T-cell content within type B and C tubers (CD3). D. Significant increase of CD3 positive cells in type B and C tubers
compared to controls. E. Almost no microglial activation can be detected in autopsy cortex (Cr3/43 staining). F. + G. Representative WM of type
B and C tubers showing an increase in microglial activation (Cr3/43). H.Quantification of the Cr3/43 positive content revealed a significant
difference between controls and type B as well as C tubers. Scale bar in g = 100μm and applies also to a, b, c, e, f and g. CO = control;
PT = perituberal cortex.
doi:10.1371/journal.pone.0157396.g003
Fig 4. White matter pathology in cortical tubers. A. Normal appearing white matter content of the temporal
lobe in a 17-years old autopsy case (MBP staining).B. + D. + E. Representative sections of WMwithin the 3
different tuber types (MBP). Scale bar in e = 100μm and applies also to a, b, and d. C. Significant reduction of
myelin content. F. Equal distribution of oligodendroglial cells among all tuber types.CO = control;
PT = perituberal cortex.
doi:10.1371/journal.pone.0157396.g004
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(X2, p = 0.011). Furthermore, carbamazepine, levetiracetam, valproic acid, topiramate, cloba-
zam and vigabatrine were the drugs of choice in this specific group, never reaching a combina-
tion of more than two given at the time of surgery. In the other subtypes various range of all
available drugs in combination of up to five were found. Hemispherotomies were not observed
in the type A group. In addition, we observed a negative correlation between histological tuber
type and age at surgery as well as duration of active epilepsy (Kendall-tau and partial; age:
p = 0.002; epilepsy duration: p = 0.004). All other clinical characteristics failed to reach signifi-
cance (Table 2).
Discussion
Over the past decade a number of studies have been published that focused on the histological
features of cortical tubers in TSC patients [14, 15, 16]. However, due to the increased number
of patients who underwent epilepsy surgery more and more tissue becomes available to investi-
gate the variability of cellular features within this highly selected patient group. Here, we pres-
ent the first comprehensive histological analysis with respect to TSC cortical tubers.
Recently, two new classification schemes were presented by task forces of the International
League Against Epilepsy (ILAE). In 2011, FCD, the most common cause of intractable epilepsy
in children,–- was addressed [17], and in 2013 a novel classification scheme for hippocampal
sclerosis was published [18]. These schemes, however, were established to distinguish distinct
entities considering clearly different clinical etiologies. Nevertheless, the new FCD classification
scheme has already proven to be more reliable with regard to inter-rater variability than previ-
ous schemes [19, 20]. Most importantly, the first reports on possible clinical value for predic-
tion of surgical outcome have been published [21, 22]. In these studies, seizure-freedom was
dependent on accurate definition of the epileptogenic zone and the subsequent extent of surgi-
cal resection [21, 22].
Until now cortical tubers have been neglected in this respect. In an attempt to meet the cur-
rent need of a better histological assessment we have identified three distinct patterns of corti-
cal tubers. Consequently, we were able to show that our tuber patterns are recognizable by
different neuropathologists and therefore reasonably applicable in different neuropathology
laboratories. In our endeavor to identify variants of TSC lesions on a histological level and to
stay within the frame of diagnostic usefulness and high accessibility we chose a panel of anti-
bodies that has been established and widely-used previously and subsequently used statistic
modeling to asses quantitative differences [23]. The normal expression pattern of the selected
Fig 5. Clinical implications. A. Representative MRI of a patient with a histological type A tuber (histology is shown in Fig 1B) characterized
by a hyperintense lesion parasaggital in the right frontal lobe (indicated by the arrow head) on T2 weighted and fluid-attenuated inversion
recovery (FLAIR) and a hypointense signal in the same area on volumetric T1 images.B.MRI of a histological type B tuber (histology is
shown in Fig 1C) with FCD-like features in the left postcentral/parietal region, showing as a hyperintense lesion on FLAIR image and a
hypointense signal on 3DT1. FCD features are recognized by thickened cortex, blurring of gray and white matter junction and a transmantal
sign.C.MRI of a histological type C tuber (histology is shown in Fig 1D) with a large calcification, characterized by deep hypointense signal
with surrounding heterogenous hyperintense signal on T2 weighted and FLAIR images and a hypointense signal in the white matter on
3DT1. The above described FCD features are seen here as well.
doi:10.1371/journal.pone.0157396.g005
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Table 2. Patients characteristics.
Classiﬁcation
type A type B type C p-value
Gender
male 6 6 6
female 1 7 2 > 0.05
localization
frontal 5 5 7
temporal 2 6 0
parietal 0 2 1
occipital 0 0 0 > 0.05
seizure frequency prior to surgery
daily 7 10 6
weekly 2 3 0 > 0.05
TSC mutation
tested/ not found 0 1 0
TSC1 1 5 2
TSC2 5 3 2
not tested 6 4 4 > 0.05
types of seizures at surgery
infantile spasms 2 3 1
focal seizures with awareness 2 5 6
focal seizures with impaired awareness 3 5 1 > 0.05
MRI classiﬁcation according to Gallagher et al. 2010 [11]
A 1 1 0
B 2 3 3
C 0 1 1
combination 4 2 2
not applicable 0 4 2 > 0.05
FCD-like features
no 4 4 3
yes 3 7 5 0.037
Side
left 1 6 3
right 6 7 5 > 0.05
type of surgery
lesionectomy 6 7 5
lobar resection 1 3 1
hemispherotomy 0 3 2 > 0.05
last known ENGEL score [12]
1 3 10 4
2 2 0 1
3 1 0 2
4 1 3 1 > 0.05
global cognitive impairment
none 3 4 0
mild 1 5 2
moderate 0 2 3
severe 3 2 3 > 0.05
(Continued)
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markers has been also evaluated in post-mortem control tissue. However, one limitation of this
study is the availability of brain tissue within the age range of the TSC subjects. An ideal experi-
mental design (including also ages ranging between 1 and 18 year of age) is difficult to achieve
and representative material from patients without any significant brain pathology is not avail-
able at all developmental ages.
There are only a few studies which report highly advanced methods of quantitative histology
on epilepsy surgery specimens [24, 25, 26, 14]. Most of these addressed very specific pathologi-
cal features to show differences in expression patterns and therefore a lot of the data were gen-
erated via a region of interest (ROI) based approach. So far, only one group has applied whole
slide scanning and compared fully automated and user-based approaches [27]. In order to
access a much broader spectrum of characteristics and obtain a more accurate diagnosis, we
choose not to follow a ROI-based approach.
The limitation of choosing to assess all available tissue is the risk to miss subtle changes
restricted to only part of the visible pathology. In light of this, our aim was not to specifically
assess cellular features but primarily to find distinctive characteristics within the histology.
Numerous studies exist to explore the pathogenetic mechanism behind the aberrant cells visi-
ble in TSC samples. However, these are often related to FCD Type IIB another pathology with
similar histological features [28, 29, 30, 31].
Despite this limitation, it was possible to address several aspects that relate to pathophysio-
logical mechanisms in tubers. In TSC patients mTORC1 activation as assessed by staining for
various forms of phospho-S6 is expected due to the genetic nature of TSC. It provides a molec-
ular explanation for the observed giant cells, although the molecular consequences of second-
hit events are less well understood. In addition, pS6 has recently been detected immunohisto-
chemically in the perituberal cortex [14] and mTORC1 activation is believed to begin in the
fetal period [32, 33]. However, we were not able to detect differences between tuber subgroups
when compared to perituberal samples suggesting that also in our study the true margins of the
lesion extent beyond the radiographically visible perituber [34].
Furthermore, our data suggests a gradient in the level of mTORC1 activation throughout all
tuber types. Our identification of patterns would improve our understanding of the molecular
and functional events during tuber pathogenesis and eventually help to find a better definition
of perituberal tissue.
Table 2. (Continued)
Classiﬁcation
type A type B type C p-value
IQ 72.50 (45–102) 59(48–107) 52(34–68) > 0.05
Autism
no 5 9 4
yes 2 3 4 > 0.05
median age at surgery
(range) 10.00 (3.00–47.00) 7.00 (0.83–22.00) 3.00 (1.00–17.00) 0.002
median duration of active epilepsy
(range) 8.00 (3.00–35.00) 4.00 (0.80–13.00) 2.21 (0.43–13.00) 0.004
All available clinical data were collected and tested for correlation with the histologically classiﬁed tuber types. Signiﬁcance levels are presented in the last
column.
doi:10.1371/journal.pone.0157396.t002
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In previous studies we demonstrated that inflammation plays an important role in the epi-
leptogenesis of cortical tubers [13, 35]. In the present study we detected increases in inflamma-
tory markers in type B and C tubers. Type A were not significantly different to controls. This
observation may argue against the hypothesis that inflammation alone may underlie the epilep-
togenicity of the tuber. Accordingly, several studies suggest increase neuronal excitability
through different mechanisms, including also a deregulation of astrocyte-mediated glutamate
uptake and release, as well as through changes in the function of both glutamate and GABA
receptors [36]
Furthermore, hypomyelination is a common feature of FCD type II, although it is not fun-
damental to make the distinction between FCD type IIA and IIB [24, 25]. Notwithstanding, the
underlying etiology is less well understood. With our set of data a lack of myelin could also be
confirmed. After all, the oligodendroglial cell count did not delineate significant changes com-
pared with controls. Findings in TSC mouse models indicate that there is a marked difference
in brain myelination when TSC1 is lost in neurons, suggesting that the reduction in myelina-
tion is secondary to mTORC1 activation in neurons, rather than reflecting a primary oligoden-
droglial abnormality. Also, previous studies sreported that the number of oligodendroglial cells
remain intact and that there is axonal loss [25, 14]. Another study suggested that, at least in
FCD type IIB there is also a maturational problem [24]. However, the different methodological
approaches may have led to these controversial results.
All together certain features of our assessment (neuronal loss, gliosis, calcification, myelin
loss and inflammation) are considered regressive changes in pathology in TSC cortical tubers
[14, 34], albeit our associations with the available clinical data suggests differently. In our
cohort of type A tuber only a limited set of AEDs were prescribed and none of these patients
underwent hemispherotomy as surgical strategy. We have to acknowledge that these parame-
ters are certainly not a reflection of electrophysiological properties but they might act as surro-
gate markers for a milder phenotype. However, in our cohort, the number of patients with type
A tuber was too small to evaluate the possible prognostic value on postsurgical seizure outcome
or other clinical parameters, which deserves further investigation in prospective studies, using
the proposed histological tuber classification.
Another striking feature was the negative association between age at surgery and histology,
with type C tuber occurring more often in very young children. This finding could be related to
the time point of tuber formation leading to such severe pathological changes already in the
early stages of cerebral development [37]. Considering this, calcification, inflammation and
increased gliosis in type C tubers may not exclusively indicate regressive changes but also a dis-
tinct pathogenesis. Furthermore, the relatively short duration of active epilepsy before surgery
is consistent with a more severe phenotype with higher seizure burden and possible comorbid
developmental problems. However, our cohort might be too small to detect subtle differences
in clinical characteristics in relation to surgical outcomes.
We collected clinical data with special attention to MRI characterization. We were unable to
detect an association between the previously proposed classification of tuber types on MRI and
our histological assessments [11]. Nevertheless, we identified a correlation between so-called
“FCD-like features” and histological type B and C tubers. We can only speculate about the sig-
nificance of such findings to help identify the epileptogenic zone, but they might give insights
into the high similarity of TSC cortical tubers and resected FCD type IIB lesions with regard to
their epileptogenicity [38]. It is clear that neuroimaging findings are increasingly relevant in
relation to identifying the epileptogenic zone [38, 39, 24].
In summary, we have identified three distinct histological patterns in TSC cortical tubers
based on quantitative histological features to increase our understanding of the differences
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among these lesions, and to lay the groundwork for further research on the functional and
molecular effects of the different tuber types.
Supporting Information
S1 Fig. Colour segmentation recipe. For extraction of the total amount of DAB staining the
following filters were used to calculate the accurate amount.
(TIF)
S2 Fig. Cluster analysis. A.Hierarchical clustering (Ward’s method) on the parameters:
SMI32 (amount of dysmorphic neurons), vimentin (amount of giant cells) and pS6-Ser235/236
(mTOR activation) identified three different tuber patterns. B. 3D dot plot of the identified pat-
terns within their clustering matrix.
(TIF)
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